GB1338043A - Process for producing virus cultures and vaccines - Google Patents

Process for producing virus cultures and vaccines

Info

Publication number
GB1338043A
GB1338043A GB1409071*[A GB1409071A GB1338043A GB 1338043 A GB1338043 A GB 1338043A GB 1409071 A GB1409071 A GB 1409071A GB 1338043 A GB1338043 A GB 1338043A
Authority
GB
United Kingdom
Prior art keywords
virus
vaccines
producing virus
virus cultures
kidney cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1409071*[A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Publication of GB1338043A publication Critical patent/GB1338043A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18161—Methods of inactivation or attenuation
    • C12N2760/18164—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB1409071*[A 1970-05-11 1971-05-10 Process for producing virus cultures and vaccines Expired GB1338043A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707017053A FR2088038B1 (pl) 1970-05-11 1970-05-11

Publications (1)

Publication Number Publication Date
GB1338043A true GB1338043A (en) 1973-11-21

Family

ID=9055329

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1409071*[A Expired GB1338043A (en) 1970-05-11 1971-05-10 Process for producing virus cultures and vaccines

Country Status (12)

Country Link
BE (1) BE766442A (pl)
CH (1) CH532659A (pl)
CS (1) CS178080B2 (pl)
DE (1) DE2121237C3 (pl)
DK (1) DK129468B (pl)
ES (1) ES390873A1 (pl)
FR (1) FR2088038B1 (pl)
GB (1) GB1338043A (pl)
HU (1) HU165705B (pl)
NL (1) NL7106379A (pl)
PL (1) PL88908B1 (pl)
RO (1) RO62179A (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801601A (nl) * 1988-06-23 1990-01-16 Centraal Diergeneeskundig Inst Een "swine-kidney" celcultuur, geschikt voor het kweken van virussen, een daaraan geadapteerde "chinese" stam van het varkenspestvirus, alsmede de hiervan afgeleide vaccins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299514A (fr) * 1960-11-25 1962-07-27 Bayer Ag Procédé de reproduction du virus de la fièvre aphteuse
DE1174016B (de) * 1962-05-18 1964-07-16 Behringwerke Ag Verfahren zur Herstellung einer Lebend-Vaccine gegen Maul- und Klauenseuche

Also Published As

Publication number Publication date
FR2088038A1 (pl) 1972-01-07
BE766442A (fr) 1971-09-16
HU165705B (pl) 1974-10-28
ES390873A1 (es) 1975-03-16
DE2121237C3 (de) 1980-03-06
DE2121237A1 (de) 1971-12-02
CH532659A (fr) 1973-01-15
RO62179A (pl) 1977-05-15
NL7106379A (pl) 1971-11-15
CS178080B2 (pl) 1977-08-31
FR2088038B1 (pl) 1973-08-10
DE2121237B2 (de) 1979-07-05
PL88908B1 (pl) 1976-10-30
DK129468B (da) 1974-10-14
DK129468C (pl) 1975-03-03

Similar Documents

Publication Publication Date Title
GB1267136A (pl)
ATE192653T1 (de) Anwendungen von acemannan
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
GB1338043A (en) Process for producing virus cultures and vaccines
GB1443948A (en) Production of immunological material
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
ES385968A1 (es) Metodo para producir una vacuna de virus de enfermedad de newcastle muy atenuado.
GB1436323A (en) Cell and virus culture systems
BE767940A (fr) Procede de preparation du bouillon de culture de macrochampignons, notamment de champignons alimentaires pour la production de l'inoculant industriel et pour la culture
GB1199251A (en) Cultivating Foot and Mouth Disease Virus
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
FR2290220A2 (fr) Nouveau vaccin antirabique
ES347035A1 (es) Procedimiento de preparacion de una vacuna contra la rabia.
GB1152934A (en) Process for the Production of a Vaccine Against Foot and Mouth Disease
GB846755A (en) Bovine rhinotracheitis vaccine and methods of production
FR2244456A1 (en) Anti-rabies vaccine - by cultivating on bovine cells
FR2244542A1 (en) Vaccines prepd from IB-RS-2- cells - for treatment of porcine pests
GB878704A (en) Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
GB1293310A (en) Vaccine
ES226832A1 (es) Un procedimiento para producir un producto de vacuna contra la poliomelitis
GB1390468A (en) Herpes simplex type 2 virus vaccine and method of production and use
FR2150799A1 (en) Equine infectious anaemia - prepn of immunising vaccine
GB1105136A (en) Vaccines comprising living protozoa of the genus theileria
GB1349362A (en) Process for preparing live virus vaccines
GB811099A (en) Improvements in or relating to methods of producing an inactivated influenza virus vaccine

Legal Events

Date Code Title Description
PS Patent sealed
435 Patent endorsed 'licences of right' on the date specified (sect. 35/1949)
PCNP Patent ceased through non-payment of renewal fee